Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant
1 clinical trials · Condition
◉ Watch Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant
| Record | Firm | Date |
|---|---|---|
| Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors (NCT06914479) | University of Michigan Rogel Cancer Center | 2026-05-22 |
Track Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant automatically
Every clearance here is in the API, with alerts when new ones post.